This article examines the available evidence, reported symptoms, risk factors, and guidance for patients and healthcare professionals navigating mental health concerns during Wegovy treatment
Commonly reported side effects in the Phase 2 trial included: Nausea (the most frequently reported adverse effect) Vomiting Diarrhoea Constipation Decreased appetite Abdominal discomfort or bloating Eructation (belching) The majority of participants who discontinued treatment did so due to gastrointestinal side effects, underscoring the importance of the slow titration schedule used in trials
Individuals with a personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia type 2 (MEN2) are typically excluded from retatrutide trials
CJC-1295 vs Ipamorelin: GHRH Analog vs GHRP Comparison for Growth Hormone Research CJC-1295 and Ipamorelin represent two complementary mechanisms for stimulating growth hormone release, which is why they are frequently combined in research settings
[PMID: 12057799] PubMed record related to this compound for laboratory literature review
Evening primrose oil has been shown to ease menstrual and menopausal problems for women